Peptidases Prevent Opioid Receptor Activation by Endogenous Opioids in the Spinal Cord

Peptidase enzymes rapidly degrade endogenous opioid peptides in the spinal cord, preventing mu-opioid receptor internalization — when peptidases are blocked, endogenous opioids become potent enough to activate their receptors.

Song, Bingbing et al.·The Journal of neuroscience : the official journal of the Society for Neuroscience·2003·Moderate Evidencein-vitro
RPEP-00859In VitroModerate Evidence2003RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Multiple peptidase inhibition in rat spinal cord slices allowed endogenous opioid peptides to accumulate and trigger mu-opioid receptor internalization, revealing that rapid enzymatic degradation normally prevents full endogenous opioid receptor activation.

Key Numbers

How They Did This

In-vitro rat spinal cord slice study. Peptidase inhibitor cocktail applied. Mu-opioid receptor internalization measured as a marker of receptor activation by endogenous opioids released by electrical stimulation.

Why This Research Matters

Boosting endogenous opioids by blocking their degradation could provide pain relief without the addiction risk of external opioid drugs — using the body's own painkillers more effectively.

The Bigger Picture

The body produces enough opioid peptides for significant pain relief — but enzymes destroy them too fast. Peptidase inhibitors could be the key to non-addictive opioid analgesia using the body's own molecules.

What This Study Doesn't Tell Us

In-vitro spinal cord slices. The degree of pain relief achievable in vivo through peptidase inhibition needs determination.

Questions This Raises

  • ?Could peptidase inhibitor drugs provide significant analgesia?
  • ?Is the endogenous opioid amount sufficient for clinical pain relief when protected?
  • ?Would chronic peptidase inhibition cause tolerance?

Trust & Context

Key Stat:
Natural brake removed When peptidases were blocked, endogenous opioids activated spinal receptors powerfully — the body has enough natural painkillers if they're protected from destruction
Evidence Grade:
Moderate in-vitro evidence with clear receptor activation data from endogenous opioid accumulation.
Study Age:
Published in 2003. Dual enkephalinase inhibitors (DENKI) are now in clinical development for pain, validating this concept.
Original Title:
Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.
Published In:
The Journal of neuroscience : the official journal of the Society for Neuroscience, 23(5), 1847-58 (2003)
Database ID:
RPEP-00859

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Can the body's own painkillers be made stronger?

Yes — this study shows natural opioid peptides in the spinal cord are destroyed before they can fully activate pain relief. Blocking the enzymes that destroy them unleashes their full analgesic potential.

Would this be addictive?

Potentially less so than external opioids. You're enhancing the body's own controlled, localized pain relief system rather than flooding all opioid receptors with a foreign drug. Dual enkephalinase inhibitors based on this concept are now in clinical trials.

Read More on RethinkPeptides

Cite This Study

RPEP-00859·https://rethinkpeptides.com/research/RPEP-00859

APA

Song, Bingbing; Marvizón, Juan Carlos G. (2003). Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 23(5), 1847-58.

MLA

Song, Bingbing, et al. "Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.." The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003.

RethinkPeptides

RethinkPeptides Research Database. "Peptidases prevent mu-opioid receptor internalization in dor..." RPEP-00859. Retrieved from https://rethinkpeptides.com/research/song-2003-peptidases-prevent-muopioid-receptor

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.